{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:33:53Z","timestamp":1683113633715},"reference-count":51,"publisher":"Japanese Society of Veterinary Science","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Veterinary Medical Science","J. Vet. Med. Sci."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1292\/jvms.16-0036","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T22:10:14Z","timestamp":1466806214000},"page":"1541-1548","source":"Crossref","is-referenced-by-count":4,"title":["Protection efficacy of the &lt;i&gt;Brucella abortus&lt;\/i&gt; ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models"],"prefix":"10.1292","volume":"78","author":[{"given":"Ae Jeong","family":"KWON","sequence":"first","affiliation":[{"name":"Veterinary Public Health, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja Young","family":"MOON","sequence":"additional","affiliation":[{"name":"Veterinary Public Health, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Kyong","family":"KIM","sequence":"additional","affiliation":[{"name":"Veterinary Public Health, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk","family":"KIM","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Gyeongsang National University, Jinju 660\u2013701, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"HUR","sequence":"additional","affiliation":[{"name":"Veterinary Public Health, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Adone, R., Francia, M., Pistoia, C., Petrucci, P., Pesciaroli, M. and Pasquali, P. 2012. Protective role of antibodies induced by <i>Brucella melitensis<\/i> B115 against <i>B. melitensis<\/i> and <i>Brucella abortus<\/i> infections in mice. <i>Vaccine<\/i> 30: 3992\u20133995.","DOI":"10.1016\/j.vaccine.2012.04.009"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Avila-Calder\u00f3n, E. D., Lopez-Merino, A., Sriranganathan, N., Boyle, S. M. and Contreras-Rodr\u00edguez, A. 2013. A history of the development of <i>Brucella<\/i> vaccines. <i>Biomed. Res. Int.<\/i> 2013: 743509.","DOI":"10.1155\/2013\/743509"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Baek, J. H. and Lee, S. H. 2010. Isolation and molecular cloning of venom peptides from <i>Orancistrocerus drewseni<\/i> (Hymenoptera: Eumenidae). <i>Toxicon<\/i> 55: 711\u2013718.","DOI":"10.1016\/j.toxicon.2009.10.023"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Baldwin, C. L. and Goenka, R. 2006. Host immune responses to the intracellular bacteria <i>Brucella<\/i>: does the bacteria instruct the host to facilitate chronic infection? <i>Crit. Rev. Immunol.<\/i> 26: 407\u2013442.","DOI":"10.1615\/CritRevImmunol.v26.i5.30"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bernu\u00e9s, A., Manrique, E. and Maza, M. T. 1997. Economic evaluation of bovine brucellosis and tuberculosis eradication programmes in a mountain area of Spain. <i>Prev. Vet. Med.<\/i> 30: 137\u2013149.","DOI":"10.1016\/S0167-5877(96)01103-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bhan, U., Lukacs, N. W., Osterholzer, J. J., Newstead, M. W., Zeng, X., Moore, T. A., McMillan, T. R., Krieg, A. M., Akira, S. and Standiford, T. J. 2007. TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. <i>J. Immunol.<\/i> 179: 3937\u20133946.","DOI":"10.4049\/jimmunol.179.6.3937"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Billard, E., Dornand, J. and Gross, A. 2007. <i>Brucella suis<\/i> prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. <i>Infect. Immun.<\/i> 75: 4980\u20134989.","DOI":"10.1128\/IAI.00637-07"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. <i>Annu. Rev. Immunol.<\/i> 13: 61\u201392.","DOI":"10.1146\/annurev.iy.13.040195.000425"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Boman, H. G. 2003. Antibacterial peptides: basic facts and emerging concepts. <i>J. Intern. Med.<\/i> 254: 197\u2013215.","DOI":"10.1046\/j.1365-2796.2003.01228.x"},{"key":"10","unstructured":"10. Bricker, B. J. and Halling, S. M. 1994. Differentiation of <i>Brucella abortus<\/i> bv. 1, 2, and 4, <i>Brucella melitensis, Brucella ovis<\/i>, and <i>Brucella suis<\/i> bv. 1 by PCR. <i>J. Clin. Microbiol.<\/i> 32: 2660\u20132666."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bricker, B. J. and Halling, S. M. 1995. Enhancement of the <i>Brucella<\/i> AMOS PCR assay for differentiation of <i>Brucella abortus<\/i> vaccine strains S19 and RB51. <i>J. Clin. Microbiol.<\/i> 33: 1640\u20131642.","DOI":"10.1128\/JCM.33.6.1640-1642.1995"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Carballar-Lejaraz\u00fa, R., Rodr\u00edguez, M. H., de la Cruz Hern\u00e1ndez-Hern\u00e1ndez, F., Ramos-Casta\u00f1eda, J., Possani, L. D., Zurita-Ortega, M., Reynaud-Garza, E., Hern\u00e1ndez-Rivas, R., Loukeris, T., Lycett, G. and Lanz-Mendoza, H. 2008. Recombinant scorpine: a multifunctional antimicrobial peptide with activity against different pathogens. <i>Cell. Mol. Life Sci.<\/i> 65: 3081\u20133092.","DOI":"10.1007\/s00018-008-8250-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chaudhari, A. A., Jawale, C. V., Kim, S. W. and Lee, J. H. 2012. Construction of a <i>Salmonella<\/i> Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens. <i>Vet. Res. (Faisalabad)<\/i> 43: 44.","DOI":"10.1186\/1297-9716-43-44"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Clapp, B., Skyberg, J. A., Yang, X., Thornburg, T., Walters, N. and Pascual, D. W. 2011. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses. <i>Infect. Immun.<\/i> 79: 4165\u20134174.","DOI":"10.1128\/IAI.05080-11"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Corbel, M. J. 1997. Brucellosis: an overview. <i>Emerg. Infect. Dis.<\/i> 3: 213\u2013221.","DOI":"10.3201\/eid0302.970219"},{"key":"16","unstructured":"16. Ferreira, P., Gama, P., Correia, J., Nunes, L., Pipa, J., Nascimento, C., Alexandre, J. C., Henriques, P. and Santos, J. O. 2008. <i>Brucella<\/i> endocarditis--case report and literature review. <i>Rev. Port. Cardiol.<\/i> 27: 1309\u20131315."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Franco, M. P., Mulder, M., Gilman, R. H. and Smits, H. L. 2007. Human brucellosis. <i>Lancet Infect. Dis.<\/i> 7: 775\u2013786.","DOI":"10.1016\/S1473-3099(07)70286-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gazit, E., Boman, A., Boman, H. G. and Shai, Y. 1995. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. <i>Biochemistry<\/i> 34: 11479\u201311488.","DOI":"10.1021\/bi00036a021"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Haines, L. R., Thomas, J. M., Jackson, A. M., Eyford, B. A., Razavi, M., Watson, C. N., Gowen, B., Hancock, R. E. and Pearson, T. W. 2009. Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18. <i>PLoS Negl. Trop. Dis.<\/i> 3: e373.","DOI":"10.1371\/journal.pntd.0000373"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Henzler-Wildman, K. A., Martinez, G. V., Brown, M. F. and Ramamoorthy, A. 2004. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. <i>Biochemistry<\/i> 43: 8459\u20138469.","DOI":"10.1021\/bi036284s"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Izadjoo, M. J., Bhattacharjee, A. K., Paranavitana, C. M., Hadfield, T. L. and Hoover, D. L. 2004. Oral vaccination with <i>Brucella melitensis<\/i> WR201 protects mice against intranasal challenge with virulent <i>Brucella melitensis<\/i> 16M. <i>Infect. Immun.<\/i> 72: 4031\u20134039.","DOI":"10.1128\/IAI.72.7.4031-4039.2004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Jawale, C. V. and Lee, J. H. 2014. A novel approach for the generation of <i>Salmonella<\/i> Gallinarum ghosts and evaluation of their vaccine potential using a prime-booster immunization strategy. <i>Vaccine<\/i> 32: 6776\u20136782.","DOI":"10.1016\/j.vaccine.2014.10.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jenssen, H., Hamill, P. and Hancock, R. E. 2006. Peptide antimicrobial agents. <i>Clin. Microbiol. Rev.<\/i> 19: 491\u2013511.","DOI":"10.1128\/CMR.00056-05"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kharb, S. and Charan, S. 2011. Mucosal immunization provides better protection than subcutaneous immunization against <i>Pasteurella multocida<\/i> (B:2) in mice preimmunized with the outer membrane proteins. <i>Vet. Res. Commun.<\/i> 35: 457\u2013461.","DOI":"10.1007\/s11259-011-9484-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kim, D. H., Son, B. G., Lim, J. J., Lee, J. J., Kim, D. G., Lee, H. J., Min, W., Rhee, M. H., Kim, K. D., Chang, H. H. and Kim, S. 2013. The role of a <i>Brucella abortus<\/i> lipoprotein in intracellular replication and pathogenicity in experimentally infected mice. <i>Microb. Pathog.<\/i> 54: 34\u201339.","DOI":"10.1016\/j.micpath.2012.09.002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kim, H. S., Willett, J. W., Jain-Gupta, N., Fiebig, A. and Crosson, S. 2014. The <i>Brucella abortus<\/i> virulence regulator, LovhK, is a sensor kinase in the general stress response signalling pathway. <i>Mol. Microbiol.<\/i> 94: 913\u2013925.","DOI":"10.1111\/mmi.12809"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Langemann, T., Koller, V. J., Muhammad, A., Kudela, P., Mayr, U. B. and Lubitz, W. 2010. The Bacterial Ghost platform system: production and applications. <i>Bioeng. Bugs<\/i> 1: 326\u2013336.","DOI":"10.4161\/bbug.1.5.12540"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lee, J. J., Lim, J. J., Kim, D. G., Simborio, H. L., Kim, D. H., Reyes, A. W., Min, W., Lee, H. J., Kim, D. H., Chang, H. H. and Kim, S. 2014. Characterization of culture supernatant proteins from <i>Brucella abortus<\/i> and its protection effects against murine brucellosis. <i>Comp. Immunol. Microbiol. Infect. Dis.<\/i> 37: 221\u2013228.","DOI":"10.1016\/j.cimid.2014.06.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Lin, Y. and He, Y. 2012. Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses. <i>J. Biomed. Semantics<\/i> 3: 17.","DOI":"10.1186\/2041-1480-3-17"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lv, Y., Wang, J., Gao, H., Wang, Z., Dong, N., Ma, Q. and Shan, A. 2014. Antimicrobial properties and membrane-active mechanism of a potential \u03b1-helical antimicrobial derived from cathelicidin PMAP-36. <i>PLOS ONE<\/i> 9: e86364.","DOI":"10.1371\/journal.pone.0086364"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Montaraz, J. A. and Winter, A. J. 1986. Comparison of living and nonliving vaccines for <i>Brucella abortus<\/i> in BALB\/c mice. <i>Infect. Immun.<\/i> 53: 245\u2013251.","DOI":"10.1128\/IAI.53.2.245-251.1986"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Murphy, E. A., Sathiyaseelan, J., Parent, M. A., Zou, B. and Baldwin, C. L. 2001. Interferon-gamma is crucial for surviving a <i>Brucella abortus<\/i> infection in both resistant C57BL\/6 and susceptible BALB\/c mice. <i>Immunology<\/i> 103: 511\u2013518.","DOI":"10.1046\/j.1365-2567.2001.01258.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Okahashi, N., Yamamoto, M., Vancott, J. L., Chatfield, S. N., Roberts, M., Bluethmann, H., Hiroi, T., Kiyono, H. and McGhee, J. R. 1996. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant <i>Salmonella<\/i> strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. <i>Infect. Immun.<\/i> 64: 1516\u20131525.","DOI":"10.1128\/IAI.64.5.1516-1525.1996"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Olsen, S. C. 2013. Recent developments in livestock and wildlife brucellosis vaccination. <i>Rev. - Off. Int. Epizoot.<\/i> 32: 207\u2013217.","DOI":"10.20506\/rst.32.1.2201"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Olsen, S. C., Boyle, S. M., Schurig, G. G. and Sriranganathan, N. N. 2009. Immune responses and protection against experimental challenge after vaccination of bison with <i>Brucella abortus<\/i> strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. <i>Clin. Vaccine Immunol.<\/i> 16: 535\u2013540.","DOI":"10.1128\/CVI.00419-08"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Pasquali, P., Rosanna, A., Pistoia, C., Petrucci, P. and Ciuchini, F. 2003. <i>Brucella abortus<\/i> RB51 induces protection in mice orally infected with the virulent strain <i>B. abortus<\/i> 2308. <i>Infect. Immun.<\/i> 71: 2326\u20132330.","DOI":"10.1128\/IAI.71.5.2326-2330.2003"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Radek, K. and Gallo, R. 2007. Antimicrobial peptides: natural effectors of the innate immune system. <i>Semin. Immunopathol.<\/i> 29: 27\u201343.","DOI":"10.1007\/s00281-007-0064-5"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Riquelme-Neira, R., Retamal-D\u00edaz, A., Acu\u00f1a, F., Riquelme, P., Rivera, A., S\u00e1ez, D. and O\u00f1ate, A. 2013. Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of <i>Brucella abortus<\/i> in BALB\/c mice. <i>Vaccine<\/i> 31: 3663\u20133667.","DOI":"10.1016\/j.vaccine.2013.06.013"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Sanakkayala, N., Sokolovska, A., Gulani, J., Hogenesch, H., Sriranganathan, N., Boyle, S. M., Schurig, G. G. and Vemulapalli, R. 2005. Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant <i>Brucella abortus<\/i> RB51. <i>Clin. Diagn. Lab. Immunol.<\/i> 12: 1429\u20131436.","DOI":"10.1128\/CDLI.12.12.1429-1436.2005"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Sang, Y. and Blecha, F. 2009. Porcine host defense peptides: expanding repertoire and functions. <i>Dev. Comp. Immunol.<\/i> 33: 334\u2013343.","DOI":"10.1016\/j.dci.2008.05.006"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Schurig, G. G., Roop, R. M. 2nd., Bagchi, T., Boyle, S., Buhrman, D. and Sriranganathan, N. 1991. Biological properties of RB51; a stable rough strain of <i>Brucella abortus<\/i>. <i>Vet. Microbiol.<\/i> 28: 171\u2013188.","DOI":"10.1016\/0378-1135(91)90091-S"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Surendran, N., Hiltbold, E. M., Heid, B., Sriranganathan, N., Boyle, S. M., Zimmerman, K. L., Makris, M. R. and Witonsky, S. G. 2011. Live <i>Brucella abortus<\/i> rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells. <i>Vet. Microbiol.<\/i> 147: 75\u201382.","DOI":"10.1016\/j.vetmic.2010.06.001"},{"key":"43","unstructured":"44. VanCott, J. L., Staats, H. F., Pascual, D. W., Roberts, M., Chatfield, S. N., Yamamoto, M., Coste, M., Carter, P. B., Kiyono, H. and McGhee, J. R. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant <i>Salmonella<\/i>. <i>J. Immunol.<\/i> 156: 1504\u20131514."},{"key":"44","doi-asserted-by":"crossref","unstructured":"45. Vila-Farres, X., Garcia de la Maria, C., L\u00f3pez-Rojas, R., Pach\u00f3n, J., Giralt, E. and Vila, J. 2012. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant <i>Acinetobacter baumannii<\/i>. <i>Clin. Microbiol. Infect.<\/i> 18: 383\u2013387.","DOI":"10.1111\/j.1469-0691.2011.03581.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46. Wilmes, M. and Sahl, H. G. 2014. Defensin-based anti-infective strategies. <i>Int. J. Med. Microbiol.<\/i> 304: 93\u201399.","DOI":"10.1016\/j.ijmm.2013.08.007"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47. Yang, L., Harroun, T. A., Weiss, T. M., Ding, L. and Huang, H. W. 2001. Barrel-stave model or toroidal model? A case study on melittin pores. <i>Biophys. J.<\/i> 81: 1475\u20131485.","DOI":"10.1016\/S0006-3495(01)75802-X"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48. Yeaman, M. R. and Yount, N. Y. 2003. Mechanisms of antimicrobial peptide action and resistance. <i>Pharmacol. Rev.<\/i> 55: 27\u201355.","DOI":"10.1124\/pr.55.1.2"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49. Yoon, H. A., Aleyas, A. G., George, J. A., Park, S. O., Han, Y. W., Hyun, B. H., Lee, J. H., Song, H. J., Cho, J. G. and Eo, S. K. 2007. Correlation between the nature of immunity induced by different immunogens and the establishment of latent infection by wild-type pseudorabies virus. <i>Res. Vet. Sci.<\/i> 83: 73\u201381.","DOI":"10.1016\/j.rvsc.2006.10.007"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50. Young, E. J. 1995. An overview of human brucellosis. <i>Clin. Infect. Dis.<\/i> 21: 283\u2013289, quiz 290.","DOI":"10.1093\/clinids\/21.2.283"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51. Zhan, Y., Liu, Z. and Cheers, C. 1996. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium <i>Brucella abortus<\/i> by different mechanisms. <i>Infect. Immun.<\/i> 64: 2782\u20132786.","DOI":"10.1128\/IAI.64.7.2782-2786.1996"},{"key":"51","doi-asserted-by":"crossref","unstructured":"52. Zhang, J., Yin, S., Guo, F., Meng, R., Chen, C., Zhang, H., Li, Z., Fu, Q., Shi, H., Hu, S., Ni, W., Li, T. and Zhang, K. 2014. A potent <i>Brucella abortus<\/i> 2308 \u0394ery live vaccine allows for the differentiation between natural and vaccinated infection. <i>J. Microbiol.<\/i> 52: 681\u2013688.","DOI":"10.1007\/s12275-014-3689-9"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/78\/10\/78_16-0036\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T22:04:02Z","timestamp":1600812242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/78\/10\/78_16-0036\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.16-0036","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}